Journal
CELL DEATH AND DIFFERENTIATION
Volume 20, Issue 3, Pages 443-455Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/cdd.2012.136
Keywords
CCN2; EGFR; anoikis; metastasis
Categories
Funding
- Department of Health, R.O.C. [DOH101-TD-PB-111-NSC007]
Ask authors/readers for more resources
CCN family protein 2 (CCN2), also known as connective tissue growth factor, is a secreting protein that modulates multiple cellular events. We previously demonstrated the metastasis-suppressive effect of CCN2 in lung cancer cells. In this study, we investigate the role of CCN2 in anoikis, a form of programmed cell death that is critical in suppressing cancer metastasis. CCN2 binds to the epidermal growth factor receptor (EGFR) and triggers ubiquitination by inhibiting the formation of the beta-pix/Cbl complex, resulting in the degradation of EGFR. Binding of CCN2 to EGFR suppresses the phosphorylation of c-Src and extracellular signal-regulated kinase but increases the expression of death-associated protein kinase, which leads to anoikis. Overall, our findings provide evidence validating the use of CCN2 as an anti-metastatic therapy in lung cancer patients, and prospect a potential therapeutic synergy between CCN2 and the anti-EGFR antibody for the treatment of lung cancer. Cell Death and Differentiation (2013) 20, 443-455; doi:10.1038/cdd.2012.136; published online 23 November 2012
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available